Philip Morris misses 1Q forecasts, volume continues decline

Philip Morris plans ‘smoke-free’ future with business restructure

Philip Morris plans ‘smoke-free’ future with business restructure

The institutional investor owned 1,682,534 shares of the company's stock after selling 304,338 shares during the period.

The stock decreased 1.13% or $1.3 during the last trading session, hitting $114.60. Oakbrook Investments LLC raised its stake in Philip Morris International by 34.6% in the third quarter. Highland Capital Management LLC now owns 79,960 shares of the company's stock worth $7,774,000 after buying an additional 300 shares during the last quarter. Philip Morris International shares last traded at $109.98, with a volume of 9,706,808 shares changing hands. BlackRock Institutional Trust Company N.A. now owns 39,355,323 shares of the company's stock worth $3,826,125,000 after buying an additional 163,627 shares during the period.

Image source: Philip Morris International. The average estimate of five analysts surveyed by Zacks Investment Research was for earnings of $1.03 per share. Financial Advisory Service Inc. increased its stake in Philip Morris International by 0.3% in the third quarter. Following the completion of the sale, the chief executive officer now directly owns 787,671 shares in the company, valued at $80,854,428.15. Has $153.935 Million Stake in Philip Morris International Inc. (NYSE:PM) saw some unusual options trading on Thursday.

David and Tom just revealed what they believe are the 10 best stocks for investors to buy right now. and Philip Morris International wasn't one of them! The stock has a market capitalization of $169.95 billion, a P/E ratio of 24.45 and a beta of 0.94. The company's 50-day moving average price is $112.40 and its 200 day moving average price is $99.25. Foundry Partners LLC's holdings in Philip Morris International were worth $619,000 at the end of the most recent quarter.

Philip Morris shareholders were nervous about the news, and that's a big part of why the stock fell almost 4% during the trading session following the morning announcement. This is an increase of 487% compared to the typical volume of 179 put options.

For the quarter ending in March, Philip Morris International earned 98 cents per share on $6.06 billion worth of revenue. Philip Morris International had a negative return on equity of 64.94% and a net margin of 9.30%. -EPS Growth (Y-o-Y): 4.1% -Analysts Estimate: $1.03 -Revenue (Q1): $16.56 Bln vs. $16.79 Bln past year. "Q1 adjusted EPS of $0.98 vs. $0.98 is $0.11 below our estimate, as total cigarette shipment volumes fell 12%, more than we expected".

Operating income for the quarter was $2,396 million, compared with $2,473 million in the previous year period. For the full year, Philip Morris expects diluted earnings per share between $4.84 and $4.99 and adjusted earnings per share of $4.48.

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, April 11th. Shareholders of record on Thursday, March 23rd were given a dividend of $1.04 per share. This represents a $4.16 dividend on an annualized basis and a yield of 3.65%. The ex-dividend date was Tuesday, March 21st. Philip Morris International's payout ratio is presently 92.86%.

TRADEMARK VIOLATION NOTICE: "Baillie Gifford & Co". Parametrica Management Ltd bought a new stake in Philip Morris International during the third quarter worth $382,000. "(PM)" was first published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this piece on another site, it was copied illegally and republished in violation of USA and global copyright laws. The original version of this news story can be accessed at https://www.thecerbatgem.com/2017/04/20/baillie-gifford-co-buys-6518-shares-of-philip-morris-international-inc-pm-updated-updated.html.

PM has been the subject of a number of research reports. Vetr cut shares of Philip Morris International from a "strong-buy" rating to a "buy" rating and set a $101.10 price target for the company.in a research report on Wednesday, January 18th. Barclays PLC increased their price target on Philip Morris International from $108.00 to $135.00 and gave the stock an "overweight" rating in a report on Wednesday, March 29th. The company now has an average rating of "Buy" and an average price target of $110.17. BlackRock Inc is the second biggest holder with 89 million shares now valued at 9.76 B million whilst Capital Research Global Investors has 74 million shares valued at 6.74 B million.

Recommended News

  • Iran's Rouhani registers to run for re-election

    It seems probable that the Pasdaran itself could produce a strong leadership figure to fill such a vacuum in the way that Gen. He is also a member of Assembly of Experts, an all-cleric body that will rule on the successor for the Supreme Leader.
    Contraceptive pills are 'making women miserable', study finds

    Contraceptive pills are 'making women miserable', study finds

    Researchers discovered that the women who took the real pills felt different, as compared to those who received a placebo. He said: 'This might in some cases be a contributing cause of low compliance and irregular use of contraceptive pills.
    Controversy after Survivor contestant outs fellow player as transgender

    Controversy after Survivor contestant outs fellow player as transgender

    These days, we may think we know what it means to be transgender, but there is a type of trans person we never hear about. Zeke is a massive Survivor fan and his point with us was very clear - he wanted to be seen as a Survivor player.
  • Facebook Takes Deeper Dive Into Augmented Reality

    Messenger will have an added feature similar to WeChat , the Chinese app that lets users multi-task from the same app. He described the previous rollout of camera functionality across all of Facebook's apps as "act one".

    Dortmund bus delayed from leaving hotel

    Monaco's other two potential opponents are Atletico Madrid - which lost last year's final to Real - and 2015 runner-up Juventus. He said: "We started well with one or two risky moves where we found some space and then conceded an unlucky goal".

    UK Labour leader comes out fighting

    Answering questions, Mr Corbyn said Labour's manifesto would be "fully costed and will be all accounted for and paid for". But Mr Corbyn has now ruled out a second vote.
  • Paris shooting: French police officer killed, attacker 'taken down'

    Paris shooting: French police officer killed, attacker 'taken down'

    After the loud bangs, she says: 'A sudden noise where we were was mistaken for gunfire and had police shouting us off the street. Donald Trump has offered his condolences to the people of France saying it looks like another terrorist attack.

    Analyst Earnings Estimation about: Occidental Petroleum Corporation's (OXY)

    The gas and oil segment explores for, develops and produces oil and condensate, natural gas liquids (NGLs) and natural gas. Cardinal Health, Inc. (NYSE:CAH) share price increased in the last trading session with a previous 52-week high of $85.82.

    Samantha Bee Viciously Revises Bill O'Reilly's Exit Statement

    There was the prospect of even more, with his audience larger in the first three months of 2017 than it has ever been. O'Reilly said in the statement at the time that he had settled only to spare his children from the controversy.
  • Google Home's assistant can now recognize different voices

    The feature will begin rolling out Thursday for Google Home users in the US , but will expand to the U.K.in the coming months. Consumers should also think about how this information could be used outside of the company, Shear said .

    Utah Congressman Jason Chaffetz Will Not Seek Re-Election, Per Sources

    Provo Mayor John Curtis said Wednesday that he would consult with his family and advisors and make a decision at a later date. Jason Chaffetz (R., Utah) decided not to run for reelection in 2018 because he is being blackmailed by Russian Federation .
    Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Reviewed By Analysts

    Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Reviewed By Analysts

    According to sentiments of 9 analysts the mean estimates of short term price target for the company's stock is marked at $62.89. On Tuesday, February 21 NELSEN ROBERT sold $6.68 million worth of Agios Pharmaceuticals Inc (NASDAQ:AGIO) or 135,364 shares.

We are pleased to provide this opportunity to share information, experiences and observations about what's in the news.
Some of the comments may be reprinted elsewhere in the site or in the newspaper.
Thank you for taking the time to offer your thoughts.